Article

Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients With Driver Mutations

2023-12-28

Abstract excerpt

<h4>Background: </h4> The efficacy of local therapies for lung cancer patients with postoperative oligo-recurrence has been reported. However, whether local therapies should be chosen over molecular targeted therapies for oligo-recurrence patients with driver mutations remains controversial. We hence aimed to investigate the optimal initial treatment strategy for oligo-recurrence in lung cancer patients with drive...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ffdc3e2a-e1f5-5edc-97f8-e4dca4e8046b
DOI: 10.20944/preprints202312.2154.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients With Driver MutationsDOI 10.20944/preprints202312.2154.v1Read

Examination of the effectiveness of local therapy for oligo-recurrence of EGFR-mutated NSCLC.Semantic proximity Read

Pattern of failure and clinical value of local therapy for oligo-recurrence in locally advanced non-small cell lung cancer after definitive chemoradiation: Impact of driver mutation status.Semantic proximity Read

Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma.Semantic proximity Read

Genomic profiling implicates candidate genes and mutagenic pathways driving lung cancer recurrenceSemantic proximity Read

Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical ResectionSemantic proximity Read

Genetic-pathological prediction for timing and site-specific recurrence pattern in resected lung adenocarcinoma.Semantic proximity Read

EGFR Mutation Impacts Recurrence in High-Risk Early-Stage Lung Adenocarcinoma in the IASLC Grading SystemSemantic proximity Read

Relative efficacies of EGFR-TKIs and immune checkpoint inhibitors for treatment of recurrent non-small cell lung cancer after surgerySemantic proximity Read

Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients.Semantic proximity Read

Is radical local therapy effective in postoperative recurrent EGFR-mutated non-small cell lung cancer?Semantic proximity Read

Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Recurrence After Lung Cancer Surgery: Consistent Prognostic Value Across EGFR, KRAS, and ALK Mutation Subgroups in a Large Real-World Cohort Running title: NLR Predicts Recurrence Across Gene Mutations in Lung CancerSemantic proximity Read

EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.Semantic proximity Read